Assignee
HANGZHOU GLUBIO PHARMACEUTICAL CO LTD
CN·0 granted patents·3 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
3 records- 0154US2025049798A1Wee1 protein kinase degradation agent and use thereofHANGZHOU GLUBIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0254US2024360150A1Isoindolinone compounds and uses thereofHANGZHOU GLUBIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0346US2024294500A1Isoindolinone compounds, and uses thereofHANGZHOU GLUBIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HANGZHOU GLUBIO PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →